Aberrant nuclear pore complex degradation contributes to neurodegeneration in VCP disease
Neuron · 2026-03 · 114 (5) · 850-867.e8
DOI: 10.1016/j.neuron.2025.11.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2026-03. Verfasst von Sandeep Kumar Dubey und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Valosin Containing Protein, Nuclear Pore, Nuclear Pore Complex Proteins, Neurodegenerative Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIAMS NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Defective nucleocytoplasmic transport (NCT) has emerged as a contributing factor in the pathogenesis of neurodegenerative diseases and aging. Valosin-containing protein (VCP) is an AAA+ATPase required for disassembly of protein complexes, and mutations in VCP cause neurodegenerative and neuromuscular diseases. We find that VCP is required for quality control of nuclear pore complexes (NPCs) by extracting selected nucleoporins from NPCs for proteasome-mediated degradation. Pathogenic VCP variants cause a reduction in nucleoporins in Drosophila, induced pluripotent stem cell (iPSC)-derived motor neurons, and muscle biopsies from patients, indicating a dominant gain-of-function mechanism. Mechanistically, disease-associated mutations in VCP result in increased recruitment to NPCs through interactions with Ufd1-Npl4, leading to the removal of a subset of nucleoporins from NPCs and disrupting NCT. These findings show that the VCP-Ufd1-Npl4 pathway regulates NPC quality control and that disease-associated variants aberrantly activate the VCP-Ufd1-Npl4 complex to degrade NPCs and disrupt NCT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Department of Molecular and Human Genetics, Jan and Dan Duncan Neurological Institute at Texas Children's Hospital, Baylor College of Medicine, Houston, TX 77030, USA; Department of Neuroscience, Baylor College of Medic…
- Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Neuroscience, Baylor College of Me…
Förderung
- NIA NIH HHS
- NIAMS NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
- Robert Packard Center for ALS Research, Johns Hopkins University
- ALS Association
- Target ALS
Zitieren
APA
Dubey, S. K., Chaubey, D., Ikenaga, C., Lin, W. W., Bellen, H. J., & Lloyd, T. E. (2026). Aberrant nuclear pore complex degradation contributes to neurodegeneration in VCP disease. Neuron, 114(5), 850-867.e8. https://doi.org/10.1016/j.neuron.2025.11.017
Vancouver
Dubey SK, Chaubey D, Ikenaga C, Lin WW, Bellen HJ, Lloyd TE. Aberrant nuclear pore complex degradation contributes to neurodegeneration in VCP disease. Neuron. 2026;114(5):850-867.e8. doi:10.1016/j.neuron.2025.11.017
BibTeX
@article{Dubey2026,
author = {Dubey, Sandeep Kumar and Chaubey, Divya and Ikenaga, Chiseko and Lin, Wen-Wen and Bellen, Hugo J and Lloyd, Thomas E},
title = {Aberrant nuclear pore complex degradation contributes to neurodegeneration in VCP disease},
journal = {Neuron},
year = {2026},
volume = {114},
number = {5},
pages = {850--867.e8},
doi = {10.1016/j.neuron.2025.11.017}
}
EUVIMED